chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received Pfizer COVID 19 Vaccine on December 17, 2020.  No issues or complaints from DOSE 1.    Pt reported to vaccination center on January 7, 2021, to receive second dose and patient received Moderna COVID 19 Vaccine in lieu of Pfizer.  At the time of 2nd vaccination dose, no issues or concerns.    On January 8, 2021, patient reported to work and was sent from nursing floor by her manager to be seen in ER as she had slight nausea today.     PER ED NOTE:  No rash/swelling or sob. vaccine was given yesterday. No cp or abd pain. Feels a little tired but otherwise fine per patient.
Fever, macule and papule rash, was treated with Acyclovir for 5 days.
Burning itch all over. Vaginal itching. heavy ministration. Eyes hurt, extreme tiredness and weak muscles. Cloudy/ foggy thinking and memory.
He got his vaccine, and on Easter he thought that he had a cramp in his leg, and asked his wife and told her that he had this.  By that afternoon he still had the cramping feeling, and started drinking water as his wife is a nurse and felt that he may be dehydrated.  Throughout the week he had a Charlie Horse pain in his left calf, and felt that it was getting worse and not going away.  The whole week he went to work and on the 7th day it started swelling and went to Hospital after he got off of work, and he saw a resident who said that his leg was swollen and told him that she was going to schedule an ultrasound.  He had that on Friday on 4/16/21, and was scheduled for 4:00 but due to the pain went to the ER and gave him IV and checked his blood work.  The ultrasound showed that he did have a blood clot and prescribed Eliquis and gave him a dose while in the ER.  He told him that he would be on 2 a dat for 7 days  and then 1 a day, but did not tell him how long.  He is supposed to see the resident this afternoon for recheck.   He is still having pain and wanting to know where he is going to do from this point.    He does work out every day at his home gym and has not smoked, and now wanting to know how this is going to affect his life from this point into the future.  He also jumps rope 3 times a day and now not able to do this.
lymph nodes are swollen; radiates to her elbows on both sides; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes are swollen) and PAIN (radiates to her elbows on both sides) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes are swollen) and PAIN (radiates to her elbows on both sides). At the time of the report, LYMPHADENOPATHY (lymph nodes are swollen) and PAIN (radiates to her elbows on both sides) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment information was unknown
Cellulitis of the right upper arm, at site of injection. Keflex 250/5ml 5ul TID
I got my first dose 12/18/20, minimal symptoms, sore arm that lasted about 24 hours, consistent with every years flu shot.   2nd dose 1/4/21, completely different experience. I was forwarned that the first dose primes the immune system, 2nd can be worse, so I was taking 600 mg Motrin q6 hours. Despite that, my arm progressively hurt worse and worse until now I can?t lift it above my waist. Full body aches and pains. Horrible chills and so cold. 102.1 F is highest temp so far, but that?s on top of scheduled Motrin.   Still glad that I got it, but man does it suck right now.
Received second dose in August 2021 my right arm in shoulder constantly has a dull ache, numbness at times, crawling sensation, and my range of motion is not the same.
huge bruise in his left arm; bruise is painful; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (huge bruise in his left arm) and PAIN (bruise is painful) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced CONTUSION (huge bruise in his left arm) and PAIN (bruise is painful). On 07-May-2021, CONTUSION (huge bruise in his left arm) had resolved. At the time of the report, PAIN (bruise is painful) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported   This case was linked to US-MODERNATX, INC.-MOD-2021-112593 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received included outcome of event changed from not recovered to recovered for events bruise, but for the event pain was not changed; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-112593:Second dose case
bleeding at time of vaccination and immediate pain 3/10.  upon return home large black and blue bruise and walnut size lump at vaccination site.  continued achy.  now at day #4 with same walnut size black and blue bruise and achy 1/10.
This is in follow-up to report(s) previously submitted on 5/16/2008. Information has been received from a physician concerning a 10 year old female with no medical history or allergies who on 28-JUN-2007 was vaccinated SC with a first 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (Lot # 653435/0561F). There was no concomitant medication. In August 2007, 3 to 4 months post vaccination the patient was found to be seronegative. No symptoms were reported. No medical attention was sought. On 30-OCT-2007, the physician drew the varicella titre, and it came back negative (<0.91). The physician stated that the patient received a second varicella shot on 04-FEB-2008. A product quality complaint was not involved. No further information is available. It was reported that the patient's brother WAES # 0801USA047032 experienced a similar adverse event following vaccination with varicella virus vaccine live (Oka/Merck). This is one of several reports received from the same source.
possible infection; redness left arm (injection site); itchy it was 4 inches wide 5 inches long; inflamed (injection site); hot to touch (injection site); hard to touch (injection site); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (itchy it was 4 inches wide 5 inches long), VACCINATION SITE INFLAMMATION (inflamed (injection site)), VACCINATION SITE WARMTH (hot to touch (injection site)), VACCINATION SITE INDURATION (hard to touch (injection site)) and INFECTION (possible infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy it was 4 inches wide 5 inches long), VACCINATION SITE INFLAMMATION (inflamed (injection site)), VACCINATION SITE WARMTH (hot to touch (injection site)), VACCINATION SITE INDURATION (hard to touch (injection site)) and VACCINATION SITE ERYTHEMA (redness left arm (injection site)). On 02-Mar-2021, the patient experienced INFECTION (possible infection). On 01-Mar-2021, VACCINATION SITE PRURITUS (itchy it was 4 inches wide 5 inches long) had resolved. At the time of the report, VACCINATION SITE INFLAMMATION (inflamed (injection site)), VACCINATION SITE WARMTH (hot to touch (injection site)), VACCINATION SITE INDURATION (hard to touch (injection site)), INFECTION (possible infection) and VACCINATION SITE ERYTHEMA (redness left arm (injection site)) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient was antibiotics due to possible infection. doctor said to get the 2nd shot the other arm, we are scheduled to get the 2nd dose on the 18th of March.  Concomitant information not provided
Feel weak; burning sensation in my chest; dizziness; neck felt really hot/neck got hotter; had red rash all over the front of me/ back of me; throat was numb; neck got redder; Vomiting; felt like I had the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like I had the flu), RASH ERYTHEMATOUS (had red rash all over the front of me/ back of me), PHARYNGEAL HYPOAESTHESIA (throat was numb), ERYTHEMA (neck got redder) and ASTHENIA (Feel weak) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (patient states that makes me sick to my stomach'). Concomitant products included METOPROLOL SUCCINATE (TOPROL), ASPIRIN [ACETYLSALICYLIC ACID] (Aspirin 325mg once a day) and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.   On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Oct-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like I had the flu) and VOMITING (Vomiting). On 06-Oct-2021, the patient experienced RASH ERYTHEMATOUS (had red rash all over the front of me/ back of me), PHARYNGEAL HYPOAESTHESIA (throat was numb), ERYTHEMA (neck got redder) and FEELING HOT (neck felt really hot/neck got hotter). On 11-Oct-2021, the patient experienced ASTHENIA (Feel weak), CHEST PAIN (burning sensation in my chest) and DIZZINESS (dizziness). The patient was treated with DEXAMETHASONE ACETATE (DECADRON [DEXAMETHASONE ACETATE]) for Adverse event, at an unspecified dose and frequency; EPINEPHRINE for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; KETOROLAC TROMETHAMINE (TORADOL) for Adverse event, at an unspecified dose and frequency and IVs for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (felt like I had the flu), RASH ERYTHEMATOUS (had red rash all over the front of me/ back of me), PHARYNGEAL HYPOAESTHESIA (throat was numb), ERYTHEMA (neck got redder), ASTHENIA (Feel weak), CHEST PAIN (burning sensation in my chest), FEELING HOT (neck felt really hot/neck got hotter), DIZZINESS (dizziness) and VOMITING (Vomiting) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
fever 36hr p/vax to 105 status epilepticus seized for an hr;tx w/phenobarbital, ativan & dilantin;
almost fainted; body pain and chills; body pain and chills; This is a spontaneous report from a non-contactable other health professional (patient). A 21-year-old female patient (pregnant: No) received first dose of BNT162B2 (Batch/lot number: EUA), intramuscularly in left arm on 06Jan2021 12:00 PM at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), celecoxib (CELEXA). The patient experienced almost fainted, body pain and chills all on 07Jan2021 03:30 AM. About 15 hours the vaccine, the patient woke up at 3 am with extreme body pain and chills and almost fainted when trying to get paracetamol (TYLENOL). The events were reported as non-serious. The adverse event was not resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No treatment received for the adverse event. The outcome of events was unknown. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Dizzy..room spinning. Vomiting nausea started day 10 prior to that severe nasal congestion day 5-7 and that got better than the vomiting. Doctor ordered zofran so can try to keep something down.
dose 1 of SHINGRIX on May 30, 2021 /  it is now 7 months /she has not received the second dose yet; Vomiting; Nausea; she experienced fluish like symptoms/felt like she had the flu; Stated was really sick; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In May 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced incomplete course of vaccination, vomiting, nausea, influenza-like symptoms and sickness. On an unknown date, the outcome of the incomplete course of vaccination, vomiting, nausea, influenza-like symptoms and sickness were recovered/resolved.   It was unknown if the reporter considered the vomiting, nausea, influenza-like symptoms and sickness to be related to Shingrix.     Linked case(s) involving the same patient:  US2022002071  Additional details were reported as follows: The reporter was a nurse and patient herself. Nurse Practitioner stated she had not received the second dose yet, which led to incomplete course of vaccination.  She stated she just remembered it was supposed to be given at 6 months and it was now 7 months. Nurse Practitioner stated she experienced fluish like symptoms. Stated was really sick, which felt like she had the flu with nausea and vomiting for 2 to 3 days. NP unable to provide the vaccine details of Lot and expiration date. She mentioned she would get the second dose as soon as possible. Information provided per content. The patient was referred to health care professional and medical information phone number provided. Consent to follow up was denied. The present case was found to be duplicate of the case US2022002071. All the future information corresponding to the case would be submitted in the present case as case of record.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022002071:same reporter
Mixed series; Past 36 days for second dose; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Mixed series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Mixed series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Mixed series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: This report refers to a case of interchange of vaccine products and inappropriate schedule of product administration with no associated AEs.
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported. No treatment information provided. The patient's husband wanted to know if his wife could receive the Johnson and Johnson vaccine as the second dose.   Reporter did not allow further contact
This spontaneous report as received from a 71 year old female consumer refers to herself with allergy about phenobarbital. On 13-MAY-2014 the patient was vaccinated with a dose of ZOSTAVAX (strength, dosage, frequency not reported). Concomitant therapies included SYNTRHOID and VIVELLE (reported as VIVELLE (hormone patch). On 14-MAY-2014, the patient experienced a stinging sensation along with feeling achy and warm at the injection site. She said "it feels like a bee sting". The patient was treated with BENADRYL (also reported as BENEDRYL) cream and ice. The outcome the events was reported as not recovered. It was reported that the patient still had redness at injection site. Additional information has been requested.
After I gave the patient a shot and sat for 15 minutes, she stated that he throat was filling itchy and that she feels "high". I asked her to stay for another 15 minutes so I can watch her but she said she would rather go home while she is feeling a little bit ok. Patient stated that she will take some benadryl once she gets home.
Mental fog; Massive head consuming headache; Extreme fatigue; This is a spontaneous report from a contactable other hcp.   A 46-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL9264), via an unspecified route of administration arm right single dose on 05Feb2021 for COVID-19 immunisation. First dose lot#EL8982, arm right (IM) was received on 15Jan2021, 10:00. Medical history included drug hypersensitivity (to sulfa drugs) from an unknown date. The patient's concomitant medications were not reported. The patient experienced mental fog on 05Feb2021 15:00, massive head consuming headache on 05Feb2021 15:00, extreme fatigue on 05Feb2021 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Feb2021. The events outcome was recovered in Feb2021  No follow-up attempts are possible. No further information is expected; Sender's Comments: Based on the information currently available, a causal relationship between event "mental fog" and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weakness, blurred vision, dizziness started 30 minutes after vaccine. Next morning weakness and blurred vision and weakness worse and pins and needle burning sensation in forearms hands lower legs and feet. Symptoms kept getting worse . Saw neurologist for normal fun and was given iv decadron to calm symptoms down.  Still suffering from these symptoms and Dr thinks it is MS flair will be getting high dose steroids to see if it can cal things down
Staff reported dizziness, nausea, headache started at 3am and has worsened throughout the day. Becoming difficult to continue working due to the side effects.
Itching, swelling, redness at site 2/11/2010 & 2/15/2010 (hyper immune rxn); mom gave ZYRTEC @ home. Left arm.
Soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter is the spouse of the patient. The age at vaccination was not reported. The patient got his 1st dose of Shingrix Vaccine, reporter stated patient had soreness at the injection site for a couple of days.  No additional information was provided.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020239733:same reporter US-GLAXOSMITHKLINE-US2020231855:Same reporter. From FU1 deleted
FELT WEIRD; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on JUL-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced felt weird. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt weird was not reported. This report was non-serious.